期刊
JOURNAL OF IMMUNOLOGY
卷 165, 期 1, 页码 548-557出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.165.1.548
关键词
-
类别
资金
- NINDS NIH HHS [K24NS02082-01] Funding Source: Medline
IL-12 is a proinflammatory cytokine secreted by dendritic cells in response to microbial Ags and mitogens, IL-12 is thought to contribute to the pathogenesis of autoimmune diseases such as multiple sclerosis (MS), This is based on studies in experimental allergic encephalomyelitis and the demonstration that PBMC IL-12 production correlates with disease progression in MS. IFN-beta-1b is an effective treatment for MS, which is thought to involve in part inhibition of proinflammatory cytokines. In this study we examined the effect of in vitro treatment with IFN-beta-1b, on mitogen-induced IL-12 production in human PBMC and myelin basic protein-specific T cell lines obtained from healthy donors and MS patients. We demonstrate that IFN-beta-1b significantly inhibits inducible IL-12 p40 up to 80% and biologically active IL-12 p70 up to 70% beginning at a dose of 10 IU/ml. This inhibition is IL-10 dependent, as it could be blocked by anti-IL-10 but not anti-IL-4 or control Abs, Thus, endogenously produced IL-10 is a required cofactor for the IFN-beta-1b inhibitory effect on IL-12 to occur, We conclude that IFN-beta-1b has a profound inhibitory effect on PBMC IL-12 production in vitro, and that this effect is IL-10 dependent. These findings are potentially relevant to the therapeutic mechanism of IFN-beta-1b in MS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据